I think the most interesting and important part of the article is the connection made to diabetes:With hindsight, I think we still missed a key component of the mechanism in that paper. I don’t think any of us were aware that the islet cells of the pancreas, which produce insulin and are destroyed in Type 1 diabetes, contain mu-opioid receptors. This had been known since at least 2014 but it is impossible to read everything and none of us had apparently picked this up. It was in a different literature unrelated to diabetes and we had not seen it.
The presence of mu-opioid receptors in the pancreas helps explains why the beta-casomorphin7 released from A1 beta-casein is inevitably attracted to the islet cells on the pancreas where it attaches to them. When the human immune system then attacks the beta-casomorphin7, there is a risk that it will also accidentally kills the insulin-producing cells themselves to which the beta-casomorphin7 is attached. That is how autoimmune diseases often work. We have known for a long time that there is a protein in the pancreas with a somewhat similar structure to beta-casomorphin7, and that this is capable of confusing the human immune system, but we did not identify the reason why beta-casomorphin7 is attracted to the pancreas in the first place.
It was only in late July of 2020 that I put those evidential streams together and made a note to myself to write to Bob about it. Some weeks later I had still to write to Bob when my wife called out to come quickly to the TV. Alas, it was a news report telling of Bob’s life and now death.
- Forums
- ASX - By Stock
- Media Updates
I think the most interesting and important part of the article...
-
-
- There are more pages in this discussion • 7,645 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
CC9
Chariot Corporation (ASX:CC9) refines Black Mountain strategy, launching Pilot Mine to seize U.S. lithium opportunity
LU7
Discover the strong preliminary feasibility of the Bécancour Lithium Refinery, showcasing resilience in a low pricing environment and a strategic plan to capitalize on future price recoveries
Add A2M (ASX) to my watchlist
(20min delay)
|
|||||
Last
$6.23 |
Change
-0.090(1.42%) |
Mkt cap ! $4.510B |
Open | High | Low | Value | Volume |
$6.30 | $6.31 | $6.17 | $6.785M | 1.089M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 5458 | $6.23 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$6.24 | 13490 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 5025 | 6.210 |
1 | 484 | 6.200 |
1 | 1000 | 6.150 |
5 | 9029 | 6.100 |
1 | 1652 | 6.050 |
Price($) | Vol. | No. |
---|---|---|
6.260 | 1604 | 1 |
6.280 | 10000 | 1 |
6.300 | 1750 | 1 |
6.320 | 700 | 1 |
6.350 | 2000 | 2 |
Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
Featured News
A2M (ASX) Chart |